(105) successfully designed a novel humanized HER2-CAR-T cell using a multi-step overlapping extension polymerase chain reaction scheme and demonstrated its inhibitory effect on HER2 positive tumor cells in vitro and induced experimental BC regression in vivo. This evidence concerns the gene ERBB2 and breast cancer.